1 Jankovic J, "Variable expression of Parkinson’s disease : A base-line analysis of the DAT ATOP cohort" 40 (40): 1529-1529, 1990
2 Jankovic J, "Variable expression of Parkinson’s disease : A base-line analysis of the DAT ATOP cohort" 40 (40): 1529-1529, 1990
3 Pont-Sunyer C, "The onset of nonmotor symptoms in parkinson’s disease(the onset pd study)" 30 (30): 229-237, 2015
4 Djaldetti R, "Quantitative measurement of pain sensation in patients with Parkinson disease" 62 (62): 2171-2175, 2004
5 Trenkwalder C, "Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson’s disease(PANDA) : A double-blind, randomised, placebo-controlled trial" 14 (14): 1161-1170, 2015
6 Broen MPG, "Prevalence of pain in Parkinson’s disease : a systematic review using the modified QUADAS tool" 27 (27): 480-484, 2012
7 Jarcho JM, "Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction" 153 (153): 744-754, 2012
8 Müller T, "Pain perception, pain drug therapy and health status in patients with Parkinson’s disease" 37 (37): 183-187, 2011
9 Hanagasi HA, "Pain is common in Parkinson’s disease" 113 (113): 11-13, 2011
10 Valkovic P, "Pain in Parkinson’s disease: A cross-sectional study of its prevalence, types, and relationship to depression and quality of life" 10 (10): 2015
1 Jankovic J, "Variable expression of Parkinson’s disease : A base-line analysis of the DAT ATOP cohort" 40 (40): 1529-1529, 1990
2 Jankovic J, "Variable expression of Parkinson’s disease : A base-line analysis of the DAT ATOP cohort" 40 (40): 1529-1529, 1990
3 Pont-Sunyer C, "The onset of nonmotor symptoms in parkinson’s disease(the onset pd study)" 30 (30): 229-237, 2015
4 Djaldetti R, "Quantitative measurement of pain sensation in patients with Parkinson disease" 62 (62): 2171-2175, 2004
5 Trenkwalder C, "Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson’s disease(PANDA) : A double-blind, randomised, placebo-controlled trial" 14 (14): 1161-1170, 2015
6 Broen MPG, "Prevalence of pain in Parkinson’s disease : a systematic review using the modified QUADAS tool" 27 (27): 480-484, 2012
7 Jarcho JM, "Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction" 153 (153): 744-754, 2012
8 Müller T, "Pain perception, pain drug therapy and health status in patients with Parkinson’s disease" 37 (37): 183-187, 2011
9 Hanagasi HA, "Pain is common in Parkinson’s disease" 113 (113): 11-13, 2011
10 Valkovic P, "Pain in Parkinson’s disease: A cross-sectional study of its prevalence, types, and relationship to depression and quality of life" 10 (10): 2015
11 Beiske AG, "Pain in Parkinson’s disease : Prevalence and characteristics" 141 (141): 173-177, 2009
12 Rukavina K, "Pain in Parkinson’s disease : New concepts in pathogenesis and treatment" 32 (32): 579-588, 2019
13 Buhmann C, "Pain in Parkinson disease : a cross-sectional survey of its prevalence, specifics, and therapy" 264 (264): 758-769, 2017
14 Tinazzi M, "Pain and motor complications in Parkinson’s disease" 77 (77): 822-825, 2006
15 한창수, "Pain and Depression: A Neurobiological Perspective of Their Relationship" 대한신경정신의학회 12 (12): 1-8, 2015
16 Duvoisin RC, "Note on the scoliosis of Parkinsonism" 38 (38): 787-793, 1975
17 Eisinger RS, "Motor subtype changes in early Parkinson’s disease" 43 : 67-72, 2017
18 Gerdelat-Mas A, "Levodopa raises objective pain threshold in Parkinson’s disease : A RIII reflex study" 78 (78): 1140-1142, 2007
19 Zella MAS, "Landscape of pain in Parkinson’s disease : impact of gender differences" 41 (41): 87-97, 2019
20 Chaudhuri KR, "King’s Parkinson’s disease pain scale, the first scale for pain in PD : An international validation" 30 (30): 1623-1631, 2015
21 Kotagal V, "Is PIGD a legitimate motor subtype in Parkinson disease" 3 (3): 473-477, 2016
22 Gandolfi M, "International Review of Neurobiology. Vol 134" Academic Press Inc 827-858, 2017
23 Stebbins GT, "How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson’s disease rating scale : comparison with the unified Parkinson’s disease rating scale" 28 (28): 668-670, 2013
24 Scott B, "Gender differences in Parkinson’s disease symptom profile" 102 (102): 37-43, 2000
25 Jankovic J, "Functional decline in Parkinson disease" 58 (58): 1611-1615, 2001
26 Gelb DJ, "Diagnostic Criteria for Parkinson Disease" 56 (56): 33-39, 1999
27 Greenbaum L, "Contribution of genetic variants to pain susceptibility in Parkinson disease" 16 (16): 1243-1250, 2012
28 Association of Korean Medicine Professors for Cardiovascular and Neurologic Medicine, "Cardiovascular and Neurological Medicine in Korean Medicine 3" WOORI Medical Books 113-114, 2016
29 Zhang LM, "Association between mutations of SCN9A gene and pain related to Parkinsonism" 30 (30): 17-20, 2013
30 Ministry of Employment and Labor, "2012Korean Longitudinal Study of Ageing(KLoSA)" Korea Employment Information Service 2013